CircSEPT9 promotes breast cancer progression by regulating PTBP3 expression via sponging miR‐625‐5p

Abstract

Abstract Background Breast cancer (BC) is a common malignancy which threatens the health of women. Circular RNAs (circRNAs) are critical factors in multiple cancers, including BC. The aim of this experiment was to investigate the molecular mechanisms of circRNA Septin 9 (circSEPT9) in the progression of BC. Methods CircSEPT9, microRNA‐625‐5p (miR‐625‐5p) and polypyrimidine tract‐binding protein 3 (PTBP3) levels were determined by quantitative real‐time polymerase chain reaction (qRT‐PCR). Western blot was performed to detect the protein levels of PTBP3, E‐cadherin and vimentin. Cell counting kit‐8 assay (CCK8) and thymidine analog 5‐ethynyl‐2′‐deoxyuridine (EDU) was utilized for proliferation examination. Flow cytometry was conducted to measure apoptosis. Transwell assay and wound healing assay to investigate the migration of BC cells. Glucose uptake and lactate production were determined by specific kits. Additionally, dual‐luciferase reporter assay and RNA immunoprecipitation (RIP) assay were utilized to verify the interaction. A murine xenograft model was established to investigate the function of circSEPT9 in BC in vivo. Results Overexpression of circSEPT9 was found in BC tissues and cells. Silencing circSEPT9 impeded BC cell proliferation, migration, epithelial–mesenchymal transition (EMT) and glycolytic metabolism but facilitated cell apoptosis in vitro. Meanwhile, circSEPT9 knockdown constrained tumor growth in vivo. MiR‐625‐5p was targeted by circSEPT9. The influence of silencing circSEPT9 on BC cell function was regained by miR‐625‐5p inhibitor. Furthermore, miR‐625‐5p regulated BC cell malignant phenotypes via downregulating PTBP3. Conclusion circSEPT9 contributed to the malignant progression of BC by up‐regulating PTBP3 via sponging miR‐625‐5p.

Keywords

• breast cancer
• circSEPT9
• miR‐625‐5p
• PTBP3